Waud Capital Partners continues to deepen its healthcare expertise with strategic promotions that strengthen its specialized sector coverage. The firm, under veteran investor Reeve Waud, has announced several key advancements in its healthcare leadership team, including Mike Lehman’s elevation to principal.
Lehman’s promotion, which comes less than four years after joining one of Chicago’s fastest-growing investment firms, demonstrates the company’s quick recognition of emerging talent. In his tenure, Lehman has made significant contributions to multiple healthcare investments, including his work with Unifeye Vision Partners and the firm’s recent Mopec Group acquisition. His advancement to principal signals the firm’s growing emphasis on specialized healthcare segments.
The healthcare team’s expansion extends beyond Lehman’s promotion. Tim Cremieux’s elevation to partner brings valuable pharmaceutical services expertise to the senior leadership. Since joining in 2017, Cremieux has shaped the investment strategy in medication supply chain optimization and pharma services. His recent leadership of the PharmAlliance platform investment showcases the firm’s commitment to these specialized sectors.
Healthcare investment success has been a hallmark of the firm’s growth, particularly evident in ventures like their behavioral health platforms. Kyle Lattner’s promotion to partner after a decade with the firm reinforces this specialization, particularly in behavioral health and medical device services.
Chris Graber, Partner and Head of the Healthcare Group, emphasizes the strategic importance of these promotions: “All of these new Partners have demonstrated extraordinary leadership, delivering value, insights and expertise to their portfolio companies and contributing to the continued success of Waud Capital.”
The strategic focus areas under the expanded healthcare leadership include:
- Pharmaceutical services and supply chain optimization
- Vision care and specialized medical services
- Behavioral health and rehabilitation services
- Medical device services and distribution
- Healthcare technology integration
These promotions come as Waud Capital positions itself for continued growth in 2025. The firm’s proven track record in healthcare investments, with more than 480 successful transactions completed since its founding, provides a strong foundation for its specialized sector approach.
The enhanced healthcare leadership team reflects the firm’s commitment to building market-leading companies through deep sector expertise. As healthcare continues to evolve, the firm’s strengthened leadership structure positions it to identify and capitalize on emerging opportunities across these specialized sectors.
